Kudos to Dan Zandberg, MD of @UPMC for one of the Most Significant @ALLIANCE_org Manuscripts 2024-2025! "Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma" in JCO #AllianceFall25 #NCI #NCTN